366 related articles for article (PubMed ID: 15886112)
1. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
3. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
Roberts T; Snow EC
J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
[TBL] [Abstract][Full Text] [Related]
5. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
6. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
[TBL] [Abstract][Full Text] [Related]
7. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
8. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
Mongini PK; Inman JK
Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
[TBL] [Abstract][Full Text] [Related]
9. B cell signaling is regulated by induced palmitoylation of CD81.
Cherukuri A; Carter RH; Brooks S; Bornmann W; Finn R; Dowd CS; Pierce SK
J Biol Chem; 2004 Jul; 279(30):31973-82. PubMed ID: 15161911
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
11. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
12. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
Fearon DT; Carroll MC
Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
[TBL] [Abstract][Full Text] [Related]
13. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
14. Complement's participation in acquired immunity.
Nielsen CH; Leslie RG
J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
[TBL] [Abstract][Full Text] [Related]
15. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
16. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
17. Enhanced B-cell activation mediated by TLR4 and BCR crosstalk.
Minguet S; Dopfer EP; Pollmer C; Freudenberg MA; Galanos C; Reth M; Huber M; Schamel WW
Eur J Immunol; 2008 Sep; 38(9):2475-87. PubMed ID: 18819072
[TBL] [Abstract][Full Text] [Related]
18. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
[TBL] [Abstract][Full Text] [Related]
19. Targeting antigen to CD19 on B cells efficiently activates T cells.
Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
[TBL] [Abstract][Full Text] [Related]
20. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
